Article
Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Epilepsy research - 1 Nov 2015
Wang Ping, Yin Tao, Ma Hong-Ying, Liu Dan-Qi, Sheng Yang-Hao, Wang Can, Zhou Bo-Ting
Abstract excerpt
OBJECTIVE: To examine the effects of cytochrome P450 3A4 (CYP3A4), cytochrome P450 3A5 (CYP3A5) and ATP-binding cassette sub-family B member 1 (ABCB1) genetic polymorphisms on carbamazepine (CBZ) plasma concentrations in Chinese patients with epilepsy using CBZ as monotherapy and bitherapy with phenytoin (PHT), phenobarbital (PB), or valproic acid (VPA). METHODS: Eighty-eight Chinese patients with epilepsy were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
